Introduction
Several studies have documented high rates of infertility in many parts of sub-Saharan Africa.'-3 In Nigeria, infertility rates as high as 30% have been reported in some areas. 4 Our recent population based study of infertility revealed a secondary infertility rate of 19 .7% among ever married women aged 15- The study drew on population based data to examine a subpopulation of cases and controls. The cases were women with primary and secondary infertility in the LGA who were identified through a comprehensive community survey of the area in 1994 . The details of the community survey have been described elsewhere. '6 In brief, 1075 ever married women aged 15 to 49 years in the area were randomly selected and interviewed in their households with a detailed structured and pretested questionnaire. The questionnaire solicited information on the sociodemographic profiles of the women and their pregnancy and contraception histories. Inquiries were also sought into their gynaecological histories with particular reference to their previous experience of symptoms consistent with sexually transmitted infections. Specifically, the women were asked a series of questions as to whether they currently had or had ever had symptoms suggesting an STI or had ever been diagnosed as having a specific STI. The symptoms checklist included repeated lower abdominal pain, yellow vaginal discharge, whitish vaginal discharge, repeated itching in the genital area, repeated painful/burning sensation on micturition, and ulcers in the genital area.
After the survey, women were classified by fertility status based on an algorithm designed for the purpose by the World Health Organisation.'7 Women classified as suffering from primary and secondary infertility formed the cases for this study. The controls were women who were classified as being fertile, and they were matched within 2 years by age and resident locality to the infertile cases. Six women in the control group were pregnant at the time of the survey. Both cases and controls were revisited within 1 month of the initial survey in their households to obtain blood samples for estimating gonococcal and treponemal antibodies. The purpose of the study was fully explained to the women and only those who agreed to participate were finally included into the study. The There was also no difference between both groups in the proportion reporting specific STI diagnoses. Out of six infertile women reporting specific STI diagnoses, two reported candidiasis, two trichomoniasis, while two reported having had gonorrhoea. The only woman reporting specific STI in the fertile group admitted having candidiasis. None of the women in the two groups reported infection with syphilis or other STI diagnoses. There were no differences between cases and controls in the number of reported abortions (three in cases and one in controls). Thus, after controlling for number of reported abortions and women's age, the pattern of observed differences in reported symptoms of previous STIs between cases and controls remained.
Regarding the serological results, 16 of the 60 infertile women (26-7%) demonstrated gonococcal antibodies in their sera compared with only four of the 53 fertile controls (7.5%). This difference was statistically significant (x2 test = 5.8; p < 0-02; odds ratio (OR) 4.5, CI = 1.3-19.9). By contrast, there was no significant difference between cases and controls in the proportions showing positive reactivity to treponemal antibodies. Six infertile women (10.0%) compared with nine fertile controls (17-0%) had positive reactivity to treponemal antibodies, a difference that was not statistically significant (X2 test = 0 7; p > 0 5; OR = 05, CI = 0-2-1-8).
Discussion
Several STIs have been implicated as possible aetiological agents in female infertility in developing countries, notably Neisseria gonorrhoea, Chlamydia, and bacterial vaginosis.' As their relative contribution to female infertility may vary in different populations, it is important that inferential approaches are used to measure their importance in communities where the prevalence of infertility is known to be high.
The results of this study indicate that a significantly higher proportion of infertile women in southwestern Nigeria have serological evidence of previous exposure to N gonorrhoea compared with fertile women. Infertile women were also more likely to report having had lower abdominal pains, vaginal discharge, and previous gonococcal infection. The results of this study and that of our earlier study which demonstrated higher rates of isolation of N gonorrhoea in the lower genital tract of infertile women compared with fertile controls'5 provide evidence that N gonorrhoea may be an important precursor of infertility among Nigerian women in this region. The results with treponemal antibodies did not show any significant differences between infertile cases and fertile controls. This is not surprising since syphilis is not known to be a sterilising STI; however, this result does provide evidence for an increasing and persisting high rate of both syphilis and N gonorrhoea in this population. The finding that several women with treponema antibodies had no history of genital ulcer reflects the inadequacy of historical evidence in confinrming previous exposure to STIs. However, this does not invalidate our results since the tendency applies equally well to cases as well as controls.
The use of serology may underestimate the true extent of gonococcal infection since antibodies tend to disappear with time. Nevertheless, for an infection that is often asymptomatic, and in a community where routine testing for STIs is not the norm, serology provides the best approach to study the association between gonococcal infection and infertility. In particular, since the study was population based, serology had the additional advantages of reduced costs, feasibility, and acceptability when used in the local community.
The results of this study suggest that secondarily infertile women in southwest Nigeria have four times the rate of previous exposure to N gonorrhoea compared with fertile women. Pelvic infection with N gonorrhoea leads to infertility as a result of the development of bilateral tubal obstruction and/or pelvic adhesions.' Direct evidence of gonococcal involve-ment in tubal damage can be found in studies which compare rates of past infection with N gonorrhoea in cases of tubal infertility versus non-tubal infertility.'2 13 Recent studies2'-23 report continuing high prevalence of symptomatic and asymptomatic gonococcal infection among different groups of Nigerian women. The infections have been attributed to the fragile nature of the health infrastructure, deteriorating socioeconomic conditions, and harmful traditional beliefs and practices. 24 The results of several qualitative studies'9 20 indicate that, owing to wrong perceptions about the causes of the illness, many STIs in Nigerian women are poorly treated and are often attended with delayed treatment. Such delay in the treatment of gonococcal infection has been reported to increase the likelihood that affected women would develop post-infectious infertility.25 Clearly, culturally appropriate educational programmes to increase awareness of the causes, dangers, and ways to prevent and treat STIs, including N gonorrhoea, would be crucial measures to reduce the burden of infertility in this population.
In conclusion, the results of this population based case-control study indicate that STIs are significantly associated with infertility among Nigerian women. In particular, women with secondary infertility have four times the rate of previous exposure to N gonorrhoea compared with fertile women. Further studies are warranted to measure the contribution of other sterilising STIs-Chlamydia and bacteria vaginosis-to female infertility in this population. Public health measures directed at reducing the burden of STIs will be crucial in preventing infertility in Nigeria.
